Hysteroscopy Technique Clinical Trial
— VASTOfficial title:
Vaginoscopy Against Standard Treatment (VAST): a Randomised Controlled Trial
Verified date | January 2018 |
Source | Birmingham Women's NHS Foundation Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Inserting a telescope into the womb to identify and treat problems with bleeding, pain or
reproduction is the commonest surgical intervention in gynaecology. This procedure is known
as a 'hysteroscopy'. The established 'traditional' technique for introducing the hysteroscope
into the womb involves the use of a 'speculum', which is inserted into the vagina. A speculum
is the metal or plastic instrument used to stretch and separate the vaginal walls so that the
opening to the womb, known as the 'cervix' can be seen. The cervix is then cleaned and
frequently grasped with a sharp toothed forcep to provide traction before the hysteroscope is
inserted. Whilst hysteroscopy is safe, it is known that pain during the procedure can lead to
a poor patient experience, and even trigger fainting episodes or failure to complete the
procedure. As the hysteroscopes have become smaller, it has been recognised that it is
possible to access the cervix and womb (i.e. 'uterus') directly using the hysteroscopic
vision without inserting any of these potentially pain inducing vaginal instruments. There is
however, uncertainty whether this newer technique known as 'vaginoscopy' or the 'no touch
technique' will minimise the pain experienced by the patient or reduce the propensity to
fainting. Futhermore, even if vaginoscopy is shown to be less painful, the technique may be
more prone to failure due to an inability to transverse the cervix and enter the uterus
without additional instruments. Post-operative infection rates of the uterus may also be
higher due to vaginal contamination.
Reducing pain and complications and improving success of the procedure as well as optimising
patients experience is important because hysteroscopy is an intimate examination, known to be
associated with significant anxiety and pain. Furthermore, the procedure is widely practised
representing the most common surgical intervention in day-to-day gynaecological practice in
the UK and elsewhere. It is therefore important, and timely given that outpatient
hysteroscopy is increasing especially in community settings, that a large, high quality
randomised controlled trial comparing 'vaginoscopy' and the 'traditional' hysteroscopy is
undertaken to resolve the uncertainty as to whether vaginoscopy is less painful, safe and
more successful than existing approaches to hysteroscopy.
Status | Completed |
Enrollment | 1600 |
Est. completion date | October 2017 |
Est. primary completion date | October 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 16 Years and older |
Eligibility |
Inclusion Criteria: - Aged 16years or over - Referred for diagnostic of operative hysteroscopy in the outpatient setting - Written informed consent obtained prior to the hysteroscopy Exclusion Criteria: - Need for hysteroscopic surgical intervention that requires cervical dilatation e.g. Novasure uterine ablation |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Birmingham Womens Hospital | Birmingham | West Midlands |
Lead Sponsor | Collaborator |
---|---|
Birmingham Women's NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hysteroscopy success (composite primary outcome) | The primary clinical outcome is a composite outcome of a completed hysteroscopy with an acceptable level of patient reported pain without a vasovagal episode or post-operative uterine infection. A composite outcome has been chosen as it was felt that all of these factors are important to classify a hysteroscopy as successful. See individual elements in secondary outcomes for a description of how they will be measured | At the time of surgery (day 1) for all elements except for infection (day 14) | |
Secondary | Procedure Pain | The main limitation of outpatient interventions is the amount of pain generated. Visual analogue scales (VAS) originally devised as measured of well-being have been successfully adapted to measure pain. This technique involves use of 10cm line of a piece of paper representing a continuum of the patients' opinion of the degree of pain. It is explained to the patient that the one extreme of the line represent "no pain at all" while the other represents "as much pain as she can possibly imagine". The subject rates the degree of pain by placing a mark on the line and scale values are obtained by measuring the distance from zero to that mark. The reliability of visual analogue scales in the assessment of pain has established as reproducible and accurate. A baseline pain questionnaire will be administered before the procedure and a further pain assessment will be made immediately after treatment. | At the time of surgery (day 1) | |
Secondary | Procedure failures | Part of the primary clinical outcome is to test whether the vaginoscopic technique reduces the number of procedure failures. Unfortunately, it is occasionally necessary to abandon outpatient hysteroscopic procedure normally because of pain or anxiety. The clinician will collect this data on the treatment form. | At the time of surgery (day 1) | |
Secondary | Infection rates | The patient will be contacted two weeks after the procedure. An infection will be defined as any of the following in the two-week period after the procedure: If the patient has received antibiotics for a urinary tract infection If the patient has received antibiotics for vaginal discharge If the patient reports 2 out of the following 3 symptoms: offensive vaginal discharge, pelvic pain and pyrexia. |
Two weeks post procedure (day 14) | |
Secondary | Vasovagal episodes | Another part of the primary outcome is assessing whether vaginoscopy reduces the number of vasovagal episodes. Vaso-vagal reactions will be defined clinically as patient is unable to leave operating couch within 5minutes of cessation of procedure due to feeling faint or dizzy or nauseous. The clinical will collect this data on the treatment form. | At the time of surgery (day 1) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06394752 -
UTERINE EVALUATION FOR THE IDENTIFICATION OF PATHOLOGY. This Study Will Compare the Intrauterine Pathology Detection Rate Between Standard of Care Hydrosonography, and a New Visual Saline Infusion Device Providing Direct Visualization of the Uterus.
|
N/A |